-
December 1, 2005 Lupin receives USFDA approval for Cephalexin Capsules
-
November 28, 2005 Lupin Receives Approval For Conducting Phase II Trials For LLL-3348 (Desoris)
-
October 24, 2005 Lupin has entered into an agreement with GSK Philippines
-
October 19, 2005 Dr. Vijay Kelkar and Mr. R A Shah join Lupin Board
-
October 19, 2005 Lupin Q2FY06 Net Profit Soars 158% to Rs. 452 million
-
September 27, 2005 Lupin – Ranbaxy Sign TB deal
-
September 26, 2005 Lupin and Aspen Sign TB Deal
-
September 2, 2005 DSM Anti-Infectives India And Lupin Enter Into A Strategic Cooperation For Cephalosporins
-
August 18, 2005 Lupin receives USFDA approval for Cephalexin Oral Suspension
In this section
Media Contacts
-
Rajalakshmi Azariah
Vice President & Global Head – Corporate Communications